Skip Navigation
Search Menu

 
Print This Page
Share this page: More
 

Search Results

Title:
Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT
Protocol Number:
J13122
Phase:
NULL
Physician:
Javier Bolanos-Meade
Sites:
Johns Hopkins Kimmel Cancer Center in Baltimore
Purpose:
Eligibility:
All US Allogeneic Transplant Donors and Recipients weighing 20 or more kg may participate in this collection of samples.
Treatment:
The goal of this study is to establish a cohort of biologic samples collected prospectively from patients treated in BMT CTN centers that will be a shared biospecimen resource for conducting future allogeneic hematopoietic stem cell transplantation (HCT) correlative studies.
Population:
Both
Last Update
05/25/2016 05:03 AM
 

Read Our Blogs
Cancer Matters: timely topics
Our Cancer: for caregivers

 

Cancer Dictionary

NCI Dictionary of Cancer Terms, a resource with more than 6,000 terms related to cancer and medicine.

 

NCI CCC